Mazagon Dock Shipbuilders Shares Plunge 7% As Q4 Net Profit Slumps 51%; Should You Buy?
Last Updated:
Shares of state-run defence PSU Mazagon Dock Shipbuilders Ltd fell over 7% in early trade on Friday; What should investors do?
Mazagon Dock Shipbuilders Share: Shares of state-run defence PSU Mazagon Dock Shipbuilders Ltd fell over 7% in early trade on Friday, May 30, following a sharp 51% year-on-year drop in net profit for Q4FY25. The company's net profit for the January-March quarter slipped to Rs 325.3 crore from Rs 663 crore in the year-ago period.
Revenue from operations for the quarter rose marginally by 2.3% YoY to Rs 3,174.4 crore, compared to Rs 3,103.7 crore in the previous year. However, operating performance was under pressure, with EBITDA plunging 83% to Rs 90 crore from Rs 524 crore.
For the full financial year, Mazagon Dock Shipbuilders reported a 25% rise in net profit to Rs 2,414 crore, up from Rs 1,937 crore in FY24, while revenue climbed 21% to Rs 11,432 crore.
At 9:18 am, shares were trading at Rs 3,485.4 on the NSE, down 7.6%.
The defence shipbuilder has recently been in focus amid reports of potential Navy orders worth Rs 44,000 crore. According to a Times of India report, the procurement of 12 advanced mine countermeasure vessels (MCMVs) will soon be placed before the Defence Acquisition Council for clearance. The MCMVs are expected to strengthen India's maritime defence by detecting and neutralising underwater mines.
Despite Friday's slide, Mazagon Dock shares have surged 130% in the past year, far outpacing the Nifty 50's 10.4% gain.
First Published:
May 30, 2025, 10:10 IST
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
United News of India
30 minutes ago
- United News of India
Sampre Nutritions Ltd Plans Strategic Fundraising Initiative to Drive Growth and Expansion
New Delhi [India], June 21: Sampre Nutritions Ltd (BSE: 530617), a leading confectionery manufacturer, has proposed fund raising initiative through various modes such as preferential issue. Communicated earlier this year to BSE, the company is likely to hold Board of Directors meeting in near future, for the shareholders to consider and approve plans for raising funds via issuance of eligible securities. The proposed capital raise may involve issuance of eligible securities of the company, in one or more ways, through public and/or private offerings, including by way of preferential issue, qualified institutions placement and / or further public offering, subject to such approvals as may be required, including approval of the shareholders of the Company. The aim is to strengthen the company's financial structure and support its ongoing expansion and diversification efforts. The management of the company commented 'This is an important step in our journey as we explore ways to expand operations, extend market penetration, and invest in long-term growth. The fundraising initiative highlights our commitment towards building a stronger, more resilient future at Sampre Nutritions Limited' As part of the process, the Board will also consider convening an Extraordinary General Meeting (EGM) or initiating a postal ballot to seek shareholder approval. Earlier in April 2024, the company successfully allotted 17 lakh equity shares at Rs 36 each following the conversion of warrants issued on a preferential basis. On October 14, 2024, the Board approved the conversion of 85 Foreign Currency Convertible Bonds (FCCBs), originally allotted on June 28, 2024, into equity shares. This resulted in the allotment of 1,19,42,116 fully paid-up equity shares of face value of Rs 10 at a conversion price of Rs 59.84 per share, increasing the company's paid-up capital to Rs. 2.09 crore comprising of 20,91,212 equity shares of face value of Rs. 10 each. Subsequently, in October 2024, the company received in-principle approval from BSE for listing of 89,91,711 equity shares of face value of Rs 10 each at a price of Rs 59.84 per equity share. Along with this, the company also received approval for issuance of 10,00,000 warrants convertible into equity shares of face value of Rs 10 each at a price of Rs 60.50 per equity share on a preferential basis. In November 2024, the company approved the allotment of 8,40,000 warrants on a preferential basis to non-promoters at a price of Rs 60.50 per warrant, each convertible into one equity share of face value Rs 10. The company was also awarded the Certificate of Recognition under the India 5000 Best MSME Awards 2024 for excellence in quality, customer satisfaction, and societal impact. The company recently announced its Q4 FY25 and FY25 consolidated financial result. The consolidated revenue from operations remained stable at Rs 25.12 crore. The company reported a consolidated net loss of Rs 7.67 crore, mainly on account of investment into subsidiaries and higher finance costs. For Q4 FY25, company reported revenue of Rs 7.76 crore, a growth from Rs 4.76 crores reported in Q4 FY24. About Sampre Nutritions Ltd: Incorporated in 1991 and headquartered in Medchal, Telangana, Sampre Nutritions Ltd is engaged in manufacturing complete range of confectionery, éclairs, candies, lollipops, toffees, powder and centre filled products. The company is instrumental to deliver the growing volumes for most of the MNC's and beside producing its own brand. The group is one stop shop for complete range of confectionary productions. It has multiple MNC's as their clients as Mondelez India Pvt Ltd, Perfetti Van Melle, Reliance, DS Group, Nestle to name a few… The promoter is also the President for Indian Confectionery Manufacturers Association and is into the industry for the past 4 decades Sampre Nutrition is the first ISO certified company in South East Asia in this category since 1995 and is the 1st HACCP Certified Company by BVQI and FSSA Version 6 certified company with receiving Multiple Quality Awards World Wide. Further the company is associated with Mondelez India Pvt Ltd for manufacturing Eclairs for the past 30 Years and the Sole Manufacturer for Eclairs for the past 8 years for India, China and South African Market.
Time of India
31 minutes ago
- Time of India
Coimbatore gets additional district consumer commission
COIMBATORE: Coimbatore has got an additional district consumer disputes redressal commission to ensure speedy disposal of pending cases at the principal district commission. Tired of too many ads? go ad free now As many as 58 cases have been transferred to the newly established additional commission so far. An official source said all pending cases from 2023 and 2024, which are ready for arguments at the principal district commission, were allocated to the additional commission for disposal. The additional commission began functioning on June 16. It is functioning from Room No 7 on the first floor of the old building on the collectorate campus. It will function three days a week—from Monday to Wednesday. However, sources noted that the additional commission lacks adequate space and is currently operating from a single room, making it difficult for the staff to maintain records or even find space to sit. Every year, around 500 new cases are filed at the principal district commission. At present, approximately 350 cases are pending before it. 'District commissions shall have jurisdiction to entertain complaints where the value of goods or services paid as consideration does not exceed Rs 50 lakh. The Consumer Protection Act, 2019, stipulates that every complaint shall be disposed of as expeditiously as possible, and an endeavour shall be made to decide the complaint within three months from the date of receipt of notice by the opposite party,' the source added.
Time of India
33 minutes ago
- Time of India
NSE moves expiry day for derivatives contracts to Tuesday from August end
The National Stock Exchange (NSE) has revised the expiry day for all index and stock derivatives contracts, shifting it from Thursdays to Tuesdays. This change will come into effect from the end of trading day on August 28 as per a circular. Currently, weekly Nifty and stock derivative contracts expire every Thursday, while monthly, quarterly, and half-yearly contracts expire on the last Thursday of the relevant expiry month. Starting August 29, all new contracts and existing open positions will reflect Tuesday as the new expiry date. The change applies across a broad spectrum of contracts: Nifty weekly, monthly, quarterly, and half-yearly contracts. Bank Nifty and other indices like Fin Nifty, Midcap Nifty, Nifty Next50 and all single stock derivatives. For example, a Nifty weekly contract originally expiring on September 4 will now expire on September 9. Similarly, the monthly Nifty contract scheduled to expire on September 25 will move to September 30. The change has been illustrated in an annexure provided by the NSE to reduce operational confusion. The revised contract files, reflecting the new expiry dates, will be available on the NSE on August 28 after market hours. Members have been advised to use updated versions of contracts. There are no other changes to the contract specifications beyond the expiry day shift. The clearing corporations will separately communicate any adjustments to the settlement schedules. The change, which aligns NSE more closely with global practices in some markets, is aimed at operational streamlining and risk reduction—though market participants will need to update trading systems and adjust internal processes accordingly.
